Chronic myeloid leukaemia (CML) is a clonal myeloproliferative stem cell disorder characterized by the constitutively active BCR‐ABL tyrosine kinase. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.